>Brookings Oregon News, Sports, & Weather | The Curry Coastal Pilot

News Classifieds Web
web powered by Web Search Powered by Google

News arrow News arrow Business arrow Brands put their hands into selling crafts

Brands put their hands into selling crafts Print E-mail
June 05, 2012 07:50 pm

 

Laurie Brand shows yarn, fabric and supplies available at her Gold Beach shop, By My Hand, on Ellensburg Avenue. The Pilot/Valiant Corley

GOLD BEACH – Laurie Brand says business has been good and she’s having the time of her life since she opened By My Hand, a yarn and fabric store at 29795 Ellensburg Ave. a few weeks ago.

Brand said husband Doug was remodeling their house.

“Doug was tearing down our den and I said ‘I need to find some place to put my stuff.’ So Doug says ‘Why not open a shop?’ So I got the store here to knit and do my stuff,” she said.

 

 She spends the day selling her yarn and fabric and scheduling classes for those wanting to learn or to improve their skills. Classes include quilting, knitting, crocheting, spinning, and then some.

“People say, ‘Laurie, you’re going to burn yourself out open seven days a week.’ But I get to do what I want all day long. I’m having a great time,” she said.

The store is open 9 a.m. to 6 p.m. Monday through Saturday and 10 a.m. to 4 p.m. on Sunday.

“I carry yarn, fabric, all the yarns and needles. I’ve got five different kinds of threads. I carry baby yarn. We have knitting classes, quilting, make it and take it classes, boa, scarves, pattern reading. The knitters come on Thursday. The spinners come on Wednesday afternoon.” Brand said.

And husband Doug has his own little shop within a shop inside By My Hand, in between remodeling projects.

He makes earrings out of fishing lures, selling them out of his Mate Bait shop.

“I don’t spend a lot of time here yet. I will spend more after I finish the house,” Doug Brand said.

He said he spent more time thinking up the name than he did in coming up with the idea of the product.

“It just came to me over time,” Doug said.

He takes his product to local shows, where he says he’s had a good response.

“I have two wholesale accounts,” he said. “But it’s fun to think big.”

 

 

Business News by Yahoo Finance

  • Economy seen regaining muscle in second quarter
    U.S. economic growth likely regained steam in the second quarter as activity picked up broadly, which would bolster expectations for a stronger performance in the last six months of the year. Gross domestic product likely grew at a 3.0 percent annual rate after shrinking at a 2.9 percent pace in the first quarter, according to a Reuters survey of economists. "I don't think the contraction we saw in the first quarter is reflective of what's truly going on in the economy," said Gus Faucher, senior economist at PNC Financial Services Group in Pittsburgh. Earlier in the second quarter, growth estimates were as high as 4 percent, but they were cut as trade, consumer spending and business investment rebounded from the winter slump by less than expected.
  • Asian shares hit six and a half year high, dollar steady before Fed
    Asian shares touched a six-and-half-year peak on Wednesday and the dollar was steady, with investors waiting for second quarter U.S. growth data as well as a U.S. Federal Reserve meeting that some believe might yield a more hawkish policy outlook. The Fed will not be updating its economic forecasts and Chair Janet Yellen will not hold a news conference following the two-day policy meeting, leaving investors' focus squarely on a statement scheduled to be released at 2 p.m. (18:00 GMT).
  • AstraZeneca buys Almirall lung drugs for up to $2.1 billion
    AstraZeneca (AZN.L) took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion for the rights to Spanish group Almirall's (ALM.MC) lung drugs. The British drugmaker, which resisted a $118 billion takeover attempt by Pfizer (PFE.N) in May, said it would pay an initial $875 million and up to $1.22 billion more if the drugs meet development and sales targets. The tie-up boosts a key therapeutic area for AstraZeneca, whose Chief Executive Pascal Soriot is determined to show his company has a strong independent future. Soriot also struck a clinical trial collaboration with Japan's Kyowa Hakko Kirin (4151.T) for a study that will evaluate a combination of the two companies' drugs in cancer - another important field for AstraZeneca.

Follow Curry Coastal Pilot headlines on Follow Curry Coastal Pilot headlines on Twitter

© Copyright 2001 - 2014 Western Communications, Inc. All rights reserved. By Using this site you agree to our Terms of Use